Initial Insights From JUPITER-02 - Toripalimab Efficacy in R/M NPC | OncLive
Initial Insights From JUPITER-02 - Toripalimab Efficacy in R/M NPC | …
1 周前
onclive.com
Targeting Recurrent and Metastatic NPC With Systemic Immunotherapy: The Role of Toripalimab and Insights From Radiation Oncology | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Targeting Recurrent and Metastatic NPC With Systemic Immunotherap…
1 周前
targetedonc.com
Treatment Landscape of Recurrent NPC: Evaluating First-Line Toripalimab in the Recurrent Setting | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Treatment Landscape of Recurrent NPC: Evaluating First-Line Toripal…
11 个月之前
targetedonc.com
Toripalimab Combo Delivers Long-Term Efficacy in Nasopharyngeal Cancer | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Toripalimab Combo Delivers Long-Term Efficacy in Nasopharyngeal …
10 个月之前
targetedonc.com
Toripalimab FLOT Regimen Improves Gastric Cancer Outcomes | Gunjan Desai posted on the topic | LinkedIn
Toripalimab FLOT Regimen Improves Gastric Cancer Outcome…
已浏览 2万 次1 个月前
linkedin.com
Dr. Rapisuwon on the Potential Utility of Toripalimab in Melanoma Subtypes | OncLive
Dr. Rapisuwon on the Potential Utility of Toripalimab in Melanom…
2021年5月4日
onclive.com
Dr Yuan on 3-Year Data for Perioperative Toripalimab/Chemo in Gastric/GEJ Cancer | OncLive
Dr Yuan on 3-Year Data for Perioperative Toripalimab/Chemo …
1 个月前
onclive.com
Phase II Trial Results of Disitamab Vedotin and Toripalimab Combina…
11 个月之前
urotoday.com
0:18
Proud to announce the launch of Toripalimab in India, the first and …
已浏览 194 次2024年11月28日
FacebookDr. Reddy's Laboratories Ltd.
Junshi Biosciences Announces Approval of sNDA for Toripalimab …
11 个月之前
thespec.com
Junshi Biosciences Announces Toripalimab's NDA Accepted by th…
2024年2月2日
finanznachrichten.de
4:56
Subcutaneous Toripalimab: Promising NSCLC Treatment | No…
2 个月之前
YouTubeThe Daily Wave
3:23
Instagram
已浏览 3.8万 次6 个月之前
Instagramthecancerdoctor10
1:26
Toripalimab #How is it different
已浏览 77 次4 个月之前
YouTubeCancer education made simple # Chandrakant…
topalliance-biosciences-inc_loqtorzi-toripalimab-nasopha…
2024年9月25日
linkedin.com
6:15
GFH018 and toripalimab combination therapy for previousl…
2014年10月27日
jove.com
12:19
Monoclonal Antibody for Severe Chronic Rhinosinusitis, Toripalim…
已浏览 204 次6 个月之前
YouTubeJAMA Network
Coherus BioSciences obtient l'examen prioritaire de la FDA pou…
7 个月之前
zonebourse.com
6:09
DIAMOND: toripalimab & radiotherapy in nasopharyngeal c…
已浏览 326 次8 个月之前
YouTubeVJOncology
5:28
What Is The Moa Of Loqtorzi Toripalimab
已浏览 73 次2024年7月18日
YouTubeRX Card Club
5:40
ASCO 2026 update l Is Toripalimab the GAME CHANGER for Resectab…
已浏览 549 次1 个月前
YouTubeEdusurg Clinics
2:52
New cancer medicine Immunotherapy for Head & Neck, …
已浏览 5061 次2024年12月17日
YouTubeDr. Pratik Patil Oncologist
4:58
Toripalimab plus chemotherapy improves 3-year survival in resect…
1 个月前
Vimeoecancer
8:24
RENOTORCH Phase III: Toripalimab + Axitinib vs Sunitinib in Advance…
已浏览 26 次6 个月之前
YouTubeCancer Research and Statistic Foundation
6:10
FDA-approved Chinese cancer drug to cost 30 times more
2023年12月12日
South China Morning PostVictoria Bela, Nick Dearman
China’s new cancer drug Toripalimab is approved in the US …
2023年11月29日
South China Morning PostVictoria Bela
Four-year outcomes with perioperative toripalimab plus che…
1 个月前
jove.com
1:33
RC48-C016: disitamab vedotin & toripalimab vs chemotherapy in H…
已浏览 77 次4 个月之前
YouTubeVJOncology
1:51
Checkpoint Inhibitors: Taking the Brakes Off the Immune System
已浏览 14.7万 次2015年6月19日
YouTubeCancer Research Institute
5:41
“药好记”药理学 第35讲-新型抗癫痫药（加巴喷丁/普瑞巴林/左乙拉西坦/拉 …
已浏览 1.2万 次2018年5月22日
bilibili药好记药理学
观看更多视频
静态缩略图占位符